Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5604-5618
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5604
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5604
Figure 3 Correlation of plasma miR-21 and miR-93 with 3-year overall survival of patients before radiotherapy and chemotherapy.
A: Receiver operating characteristic (ROC) curve of miR-21 for assessing 3-year overall survival (OS); B: ROC curve of miR-93 for assessing 3-year OS; C: Correlation of miR-21 expression (≤ 5.60/> 5.60) with 3-year OS of esophageal squamous cell carcinoma (ESCC) patients; D: Correlation of miR-93 (≤ 3.87/> 3.87)with 3-year OS of ESCC patients.
- Citation: Wang WT, Guo CQ, Cui GH, Zhao S. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(37): 5604-5618
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5604.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5604